Google
 
Web www.vitaminlore.com
www.eniva.com

Methyldopa

Also indexed as: Aldomet®

Combination drugs: Aldoclor®, Aldoril®

Methyldopa is a drug used to lower blood pressure in people with hypertension (high blood pressure).

Interactions with Dietary Supplements

Iron
Iron supplements have been found to decrease methyldopa absorption.1 2 Taking methyldopa two hours before or after iron-containing products can help avoid this interaction.

Vitamin B12
Methyldopa can decrease vitamin B12 levels, thus increasing the risk of vitamin B12 deficiency.3

Sodium
Excess dietary sodium (salt) intake can cause fluid retention and interfere with the blood pressure lowering action of methyldopa.4 Reducing the use of table salt and heavily salted foods during methyldopa therapy reduces the likelihood of this interference.

Interactions with Foods and Other Compounds

Food
Food can interfere with methyldopa absorption.5 Taking methyldopa one hour before or two hours after eating can prevent this interference.

Summary of Interactions for Methyldopa

Depletion or interference Vitamin B12*
Adverse interaction Sodium
Side effect reduction/prevention None known
Supportive interaction None known
Reduced drug absorption/bioavailability Iron

For the convenience of the reader, the information in the summary is categorized as follows: “Depletion or interference” indicates the drug may deplete or interfere with the absorption or function of the supplement or herb. “Adverse interaction” indicates that the supplement or herb used together with the drug may result in undesirable effects. “Side effect reduction/prevention” indicates the supplement or herb may reduce the likelihood and/or severity of a potential side effect caused by the drug. “Supportive interaction” indicates the supplement or herb may support or aid the function of the drug. “Reduced drug absorption/bioavailability” indicates that the supplement or herb may decrease the absorption and/or activity of the drug in the body. An asterisk (*) next to an item in the summary indicates that the interaction is supported only by weak, fragmentary, and/or contradictory scientific evidence.

References:

1. Campbell NR, Hasinoff BB. Iron supplements: A common cause of drug interactions. Brit J Clin Pharmacol 1991;31:251–5.

2. Campbell N, Paddock V, Sundaram R. Alteration of methyldopa absorption, metabolism, and blood pressure control caused by ferrous sulfate and gluconate. Clin Pharmacol Ther 1988;43:381–6.

3. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 74.

4. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 171–2 .

5. Holt GA. Food & Drug Interactions. Chicago: Precept Press, 1998, 170–1.